PolyPid's senior management will attend the J.P. Morgan 36th Annual Healthcare Conference, to be held on January 8 - 11, 2018 in San Francisco, California, USA.
PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.
Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.